CN113663217A - 增强肿瘤治疗场效果的电场发生系统、控制方法及装置 - Google Patents
增强肿瘤治疗场效果的电场发生系统、控制方法及装置 Download PDFInfo
- Publication number
- CN113663217A CN113663217A CN202110955232.2A CN202110955232A CN113663217A CN 113663217 A CN113663217 A CN 113663217A CN 202110955232 A CN202110955232 A CN 202110955232A CN 113663217 A CN113663217 A CN 113663217A
- Authority
- CN
- China
- Prior art keywords
- electric field
- designed
- drug
- target tissue
- electrode patches
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005684 electric field Effects 0.000 title claims abstract description 125
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 61
- 238000011282 treatment Methods 0.000 title claims abstract description 44
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000005669 field effect Effects 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 94
- 229940079593 drug Drugs 0.000 claims abstract description 53
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 43
- 230000000694 effects Effects 0.000 claims abstract description 42
- 238000012377 drug delivery Methods 0.000 claims abstract description 22
- 238000013461 design Methods 0.000 claims description 18
- 238000002560 therapeutic procedure Methods 0.000 claims description 13
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 6
- 238000004590 computer program Methods 0.000 claims description 4
- 108010006654 Bleomycin Proteins 0.000 claims description 3
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims description 3
- 229940009456 adriamycin Drugs 0.000 claims description 3
- 229960001561 bleomycin Drugs 0.000 claims description 3
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims description 3
- 229960004562 carboplatin Drugs 0.000 claims description 3
- 190000008236 carboplatin Chemical compound 0.000 claims description 3
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 3
- 229960004316 cisplatin Drugs 0.000 claims description 3
- 229960004964 temozolomide Drugs 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 abstract description 8
- 230000003014 reinforcing effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 35
- 230000003287 optical effect Effects 0.000 description 6
- 230000011278 mitosis Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036456 mitotic arrest Effects 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000008880 microtubule cytoskeleton organization Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000020347 spindle assembly Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36002—Cancer treatment, e.g. tumour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110955232.2A CN113663217A (zh) | 2021-08-19 | 2021-08-19 | 增强肿瘤治疗场效果的电场发生系统、控制方法及装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110955232.2A CN113663217A (zh) | 2021-08-19 | 2021-08-19 | 增强肿瘤治疗场效果的电场发生系统、控制方法及装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113663217A true CN113663217A (zh) | 2021-11-19 |
Family
ID=78544055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110955232.2A Pending CN113663217A (zh) | 2021-08-19 | 2021-08-19 | 增强肿瘤治疗场效果的电场发生系统、控制方法及装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113663217A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59812897D1 (de) * | 1997-04-23 | 2005-08-04 | Micronas Gmbh | Vorrichtung zum behandeln von malignen, tumorösen gewebebereichen |
CN103861202A (zh) * | 2014-03-18 | 2014-06-18 | 苏州文曲生物微系统有限公司 | 一种利用空心电极针电穿孔给药的装置 |
CN112869871A (zh) * | 2021-01-11 | 2021-06-01 | 杭州维那泰克医疗科技有限责任公司 | 消融装置及其控制方法、装置、系统、存储介质 |
CN113018682A (zh) * | 2021-02-25 | 2021-06-25 | 杭州维那泰克医疗科技有限责任公司 | 细胞分裂抑制装置及其控制方法、装置、系统、存储介质 |
CN113082519A (zh) * | 2021-04-30 | 2021-07-09 | 杭州维那泰克医疗科技有限责任公司 | 用于破坏或者抑制病变细胞分裂的装置及其控制方法 |
-
2021
- 2021-08-19 CN CN202110955232.2A patent/CN113663217A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59812897D1 (de) * | 1997-04-23 | 2005-08-04 | Micronas Gmbh | Vorrichtung zum behandeln von malignen, tumorösen gewebebereichen |
CN103861202A (zh) * | 2014-03-18 | 2014-06-18 | 苏州文曲生物微系统有限公司 | 一种利用空心电极针电穿孔给药的装置 |
CN112869871A (zh) * | 2021-01-11 | 2021-06-01 | 杭州维那泰克医疗科技有限责任公司 | 消融装置及其控制方法、装置、系统、存储介质 |
CN113018682A (zh) * | 2021-02-25 | 2021-06-25 | 杭州维那泰克医疗科技有限责任公司 | 细胞分裂抑制装置及其控制方法、装置、系统、存储介质 |
CN113082519A (zh) * | 2021-04-30 | 2021-07-09 | 杭州维那泰克医疗科技有限责任公司 | 用于破坏或者抑制病变细胞分裂的装置及其控制方法 |
Non-Patent Citations (2)
Title |
---|
吴丹: "《静脉治疗技术操作规范与管理》", vol. 1, 31 July 2015, 中国科学技术大学出版社, pages: 157 * |
张兴安等: "《静脉麻醉理论与实践》", vol. 1, 31 August 2015, 广东科技出版社, pages: 43 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220313346A1 (en) | Method and device for controlling output of radiofrequency ablation power, and radiofrequency ablation system | |
EP3655099B1 (en) | Energy modulation of a cyclotron beam | |
CN109661210A (zh) | 不可逆电穿孔设备及其操作方法 | |
Palma et al. | Assessment of the quality of very high-energy electron radiotherapy planning | |
US10213625B2 (en) | Proton irradiation using spot scanning | |
US20070228304A1 (en) | Particle beam irradiation system | |
US9452300B2 (en) | Systems and methods of controlling a proton beam of a proton treatment system | |
US11980775B2 (en) | Automatic generation of radiation treatment plan optimization objectives | |
US9308394B2 (en) | Particle beam irradiation system and operating method | |
CN112869871B (zh) | 消融装置及其控制方法、装置、系统、存储介质 | |
Nichols et al. | Proton therapy for pancreatic cancer | |
Corrado et al. | Palliative electrochemotherapy in primary or recurrent vulvar cancer | |
CN113663217A (zh) | 增强肿瘤治疗场效果的电场发生系统、控制方法及装置 | |
Tas et al. | An investigation of the dose distribution effect related with collimator angle in volumetric arc therapy of prostate cancer | |
Li et al. | Improvements in dose accuracy delivered with static‐MLC IMRT on an integrated linear accelerator control system | |
CN113476746A (zh) | 抑制病变细胞分裂的设备、控制方法及控制装置 | |
CN113476742A (zh) | 抑制病变细胞分裂系统及其控制方法 | |
Ke-Ping et al. | Reduction of atrial fibrillation in remotely monitored pacemaker patients: results from a Chinese multicentre registry | |
CN104519957A (zh) | 用于控制在iort期间输送的电子束脉冲的放射剂量控制装置 | |
Cetnar et al. | Commissioning of a linear accelerator producing ultra‐high dose rate electrons | |
KR20180015061A (ko) | 플라즈마 약물 적용 장치 | |
JP2020528802A (ja) | 哺乳動物の望ましい組織に電気パルスを送達するためのパルス発生装置 | |
US9839794B2 (en) | Particle beam therapy apparatus | |
Karger et al. | Photon and carbon ion irradiation of a rat prostate carcinoma: does a higher fraction number increase the metastatic rate? | |
Miller et al. | Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220107 Address after: 310018 room 3318, third floor, international innovation and Expo Center, 267 kekekeyuan Road, Baiyang street, Qiantang District, Hangzhou City, Zhejiang Province Applicant after: Hangzhou Yousheng Medical Technology Co.,Ltd. Address before: Room 101-106, 109 (1), building 8, No.20, kejiyuan Road, Qiantang New District, Hangzhou City, Zhejiang Province 310018 Applicant before: Hangzhou vena Anke Medical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230410 Address after: 310018 room 107-109, room 201-210, room 213-215, building 6, No. 400, Fucheng Road, Xiasha street, Qiantang District, Hangzhou, Zhejiang Province Applicant after: Hangzhou vena Anke Medical Technology Co.,Ltd. Address before: 310018 room 3318, third floor, international innovation and Expo Center, 267 kekekeyuan Road, Baiyang street, Qiantang District, Hangzhou City, Zhejiang Province Applicant before: Hangzhou Yousheng Medical Technology Co.,Ltd. |